The leading #raredisease #pharmaceuticalcompanies have experienced unprecedented success uncovering undiagnosed and misdiagnosed patients and their #healthcare ecosystems using IPM's Patient Finding and HCP Mapping. Find out how. Find out now. bit.ly/3xIXMuX

The typical drug commercialization approach is falling short for specialty and rare conditions. IPM.ai helps drive better decisions during the product lifecycle via augmented intelligence. Find out how. Find out now. bit.ly/3mOQn8e

How do you focus on the highest value patient targets and maximize engagement channels with HCPs for disease interception and therapy education? Found out how. Find out now. #AugmentedIntelligence #CommericalEffectiveness #raredisease #pharma bit.ly/3xoLTKk

IPM.ai Recognized as One of the World’s Most Innovative Companies in 2022 by Fast Company hubs.ly/Q015BZl20

Don't miss CEO Ron Elwell as he hosts an important discussion with all stars Michael R Crawford, Irene Dankwa-Mullan MD MPH and Evon Okidi on #healthequity and the use of inclusive #AI and the path to equitable #precisionmedicine. #RealChemRHE bit.ly/3mPRvss

We are honored to have been recognized by @PM360 as 2021 Innovative Startup! IPM.ai is empowering the life sciences pioneers to make precision medicine an analytical reality. #PatientFindingPioneers #precisionmedicine #RareDisease bit.ly/3IXAMgD

Learn how to drive better decisions during the product lifecycle via augmented intelligence and make the promise of #precisionmedicine an analytical reality. Download our whitepaper here! #PatientFindingPioneers #rarediseases #patientpopulations bit.ly/2X6sIqx

Missed our webinar? Curious to learn how IPM.ai partnered w/ @KyowaKirin_US to uncover undiagnosed patients, better understand their diagnostic & treatment journey & map treating HCPs to target for disease education & therapy orientation? bit.ly/3iGX2Qc

Conventional #clinicalstudy recruitment methods for #rarediseases don’t work. IPM.ai accelerates #clinicalstudies of life saving therapies for rare conditions, leading to optimal commercial and patient outcomes quicker and with less risk. bit.ly/3mptJ5w

Building a rare disease franchise? Register for our live webcast with @KyowaKirin_US where we'll discuss how IPM.ai helped Kyowa Kirin to implement ML/AI-based patient finding to uncover undiagnosed patients. #PatientFindingPioneers bit.ly/3ifNmMa

Learn how @johntgarcia sourced IPM.ai to use #AI to better understand the clinical symptomatology of undiagnosed #patients suffering from a devastating rare disease. #artificialintelligence #raredisease #realworlddata ipm.ai/en/blog/john-garcia-a…

Specialty and #raredisease drug development is one of the most active and fastest growing areas in drug R&D... Learn how IPM.ai accelerates the successful development, study, launch and commercialization of #precisionmedicine. bit.ly/31UNZSS

The development, clinical study, launch and commercialization of specialty/rare disease therapies demands a new analytics approach, one very different from what is traditionally utilized for common conditions. IPM.ai #raredisease #orphandrugs #predictiveanalytics

With #RWD and modern analytical approaches utilizing #machinelearning and #artificialintelligence, we can observe the degree to which any HCP behaves like a defined specialty. bit.ly/3s3SkOh

Our own Ron Elwell chats with W2O Group's Aaron Strout during W2O's 7th annual #digitalhealth summit. Join us as we explore how #artificialintelligence and #rwd can be utilized to overcome the challenges of commercializing therapies for #raredisease bit.ly/395YHJl

“@W2OGroup brings @Swoop and @ipm_ai access to additional resources, health care expertise and opportunities to... help life sciences companies uncover, activate and ultimately engage their ideal patient populations and health networks” - Ron Elwell bit.ly/3s2jypG

We are excited to announce @ipm_ai's very own Graham Jones PhD and Julieanna Gubitosa as presenters at the All-Virtual 62nd #ASH20 Annual Meeting and Exposition. Can’t wait for you all to check it out! #predictiveanalytics #raredisease #datascience bit.ly/33FIHft

"You can create a powerful resource for the identification of new treatment hypotheses for #rarediseases – and an opportunity to address severe unmet needs." #genomics #artificialintelligence bit.ly/3on2Mja

Using #AI and #RWD to find the right patient for the right clinical trial is critical in the midst of Covid-19. This tech helps pharma companies with their mission to commercialize critical therapies and moves #precisionmedicine from promise to reality. bit.ly/3677D1t